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Breast cancer-related lymphedema is a chronic complication of breast cancer treatment. It can 
result not only in physical discomfort and disfigurement but also in substantial impairment of 
daily activities. The public health importance of this study is to determine what, if any, factors 
contribute to an increased risk of lymphedema as well as to establish which subgroups of patients 
are at increased risk. Once the factors that influence the development of lymphedema are 
clarified, such findings can be used to develop preventive measures.  
In 2006, a 1:2 matched case-control study was carried out to determine significant 
predictors associated with breast cancer-related lymphedema. The results of the study showed 
that infection of the dominant arm, level of hand use and BMI would be significant predictors to 
cause lymphedema. Although the development of lymphedema still needs to be taken into 
account in clinical practice, this case-control study confirmed that some of risk factors can be 
used in prediction of lymphedema for breast cancer survivors. 
Because there is no precise incidence of lymphedema at present, the present study used the 
incidence rate from an independent study to predict probabilities of lymphedema for a group of 
breast cancer survivors by utilizing some confirmed risk factors.  
 iv 
 This study used Bayes’ Theorem to develop an estimator for the probability of 
lymphedema given various combinations of BMI, infection, and level of hand use. The delta 
method was used to estimate the variance of predicted lymphedema probabilities. The results 
consist of a list of lymphedema probabilities for different combinations of risk factors, as well as 
95% confidence limits for these probabilities. Patients who have BMI 25kg/m2, infection, and 
medium/high of occupational/hobby hand use would have the highest risk of lymphedema 
(76.71%) after breast cancer surgery.  
≥
The goal of this analysis is to address issues in lymphedema formation, to determine 
whether a set of confirmed risk factors can predict lymphedema, and to estimate the probability 
of lymphedema in the final model. A well-established lymphedema predicting system for the 
general breast cancer survivors should be seriously taken consideration in the future. 
 v 
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 1.0  INTRODUCTION 
In the United States, breast cancer is the most common type of cancer and the second leading 
cause of cancer-related death in women (AmericanCancerSociety 2008). However, breast cancer 
mortality rates have declined recently as a consequence of advances in early detection as well as 
more wide-spread application of effective adjuvant therapies. In other words, breast cancer 
seems no longer to be a life-threatening disease and patients with breast cancer may have longer 
expected survival than previously. Although a variety of therapeutic interventions improve the 
life expectancy of breast cancer patients, complications and disabilities following breast cancer 
treatment still significantly decrease the quality of life for breast cancer survivors 
(BreastCancerOrg.). 
1.1 BACKGROUND OF LYMPHEDEMA 
Lymphedema is one of the most common complications after breast cancer surgery and 
approximately 15% to 20% breast cancer patients suffer this complication following breast 
cancer treatment (Petrek et al. 2000). It is caused by a build-up of lymph fluid in the tissues 
following breast cancer surgery or radiotherapy. Our bodies have a network of lymph nodes and 
lymph vessels that carry lymph fluid, similar to the way blood vessels circulate blood to all parts 
of the body. During surgery for breast cancer, lymph nodes and vessels are removed from the 
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 underarm, changing the way the lymph fluid flows within that side of the upper body. This 
makes it more difficult for fluid in the arm to circulate to other parts of the body. If the remaining 
lymph vessels cannot remove enough of the fluid in the breast and underarm area, the excess 
fluid builds up and causes swelling, or lymphedema. The same situation would happen when 
using radiation treatment (Morrell et al. 2005). Since a cure has not been established at the 
present time, prevention of lymphedema is of key importance. 
1.2 PREDICTING FACTORS 
In general, risk factors of lymphedema are classified into three categories, treatment-related 
factors, disease-related factors, and patient-related factors. 
1.2.1 Treatment-related factors 
Type of surgery, radiotherapy, chemotherapy and other combined treatments are treatment-
related factors for lymphedema (Geller et al. 2003; Soran et al. 2006). Nowadays, surgeons use 
more often conservative surgical procedures (lumpectomy, or modified radical mastectomy) 
rather than the traditional mastectomy. Patients who undergo lumpectomy also receive radiation 
therapy afterwards in order to eliminate any cancer cells that may be present in the remaining 
breast tissue.  
Axillary lymph node dissection (ALND) is performed to determine whether cancer has 
spread beyond the breast. Cancer cells found in the lymph nodes suggest that the disease may 
have spread to other parts of the body, and surgeons usually remove most of lymph nodes in the 
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 underarm area to control tumor spreading. There are two options for doing axillary lymph node 
dissection. The first option is to do a complete exploration in the underarm area for lymph nodes 
and to remove as many as possible. The second option is to do a sentinel lymph node biopsy 
(SNLB) which is a new procedure allowing the surgeon to remove many fewer lymph nodes. 
The sentinel lymph node is the first lymph node to which cancer is likely to spread from the 
primary tumor. Cancer cell may appear in the sentinel node before spreading to other lymph 
nodes. If SNLB is done and the sentinel lymph node does not contain cancer cells, the rest of 
regional lymph nodes may not need to be removed.  
Radiation therapy is usually combined with surgery to treat breast cancer. In most studies, 
radiation therapy has been found to be a major and independent risk factor for the development 
of upper limb lymphedema (Kiel et al. 1996; Ozaslan et al. 2004; Starritt et al. 2004). Even 
without surgery, axillary radiation was associated with an increased incidence of lymphedema 
(Johansen et al. 2000; Kwan et al. 2002).  
Some authors reported that there is no relationship between type of surgery and 
lymphedema (Geller et al. 2003; Powell et al. 2003; Soran et al. 2006). Patients receiving breast-
conserving surgery had no difference in arm swelling relative to patients receiving mastectomy. 
The combination of ALND and radiation therapy has proved to be a strong predictor of 
lymphedema (Ozaslan et al. 2004). 
1.2.2 Disease-related factors 
Disease-related risk factors for lymphedema include tumor stage, nodal status, the number of 
lymph nodes excised, and the location of the tumor (Geller et al. 2003; Powell et al. 2003; Soran 
et al. 2006). Breast cancer patients would be classified by their tumor stage ranging from stage 0 
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 to stage 4. If a breast tumor measures larger than 5 centimeters and there is significant 
involvement of lymph nodes and tumor spreading, such patients are classified as being in 
later/advanced stage (stage 3 or stage 4). The results for testing the relationship between these 
disease-related factors and lymphedema remain inconsistent in reported literatures. The reason 
for that is still unclear. 
1.2.3 Patient-related factors 
Patient-related factors that have been associated with lymphedema include age at diagnosis, 
BMI, hypertension, infection, and limb use (Geller et al. 2003; Powell et al. 2003; Soran et al. 
2006). Among patient-related factors, BMI is the most significant factor to predict lymphedema. 
Increased BMI ( 25 kg/m2) has been reported to be an important factor that increases the risk 
for lymphedema development (Werner et al. 1991; Ozaslan et al. 2004). 
≥
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 1.3 RESEARCH STATEMENT 
The risk factors of lymphedema in breast cancer patients have been studied in several trials but 
the etiology of lymphedema is still not completely understood. A predicting tool for lymphedema 
should be created to help physicians and breast cancer patients understand how to prevent and 
control lymphedema. Soran et al. (2006) tested a set of risk factors of lymphedema and found 
that postoperative infection of the ipsilateral arm, level of hand use, and body mass index (BMI) 
were three statistically significant factors to predict the risk and severity of lymphedema. The 
present study used the significant predictors of lymphedema from Soran et al. (2006) and 
estimates the incidence probability of lymphedema in breast cancer surgery patients. The aim of 
our study is to investigate whether these three risk factors could accurately predict lymphedema. 
The results can be useful to guide physicians and breast cancer patients to prevent or lower the 
risk of lymphedema in favor of determining the most powerful predictors of lymphedema for the 
general population. 
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 2.0  REVIEW OF THE RELEVANT LITERATURE 
The improvement in the life expectancy of women with breast cancer raises important questions 
about how to control the complications following breast cancer treatment. Lymphedema is the 
most common and troublesome complication leading to decreased quality of life for breast 
cancer survivors (Soran et al. 2006). The etiology of lymphedema has been evaluated in many 
published papers but not all of the factors that contribute to the condition and the nature of their 
interaction have been identified. Recent public concern has focused on the efficacy of preventive 
strategies and therapeutic interventions in the management of lymphedema formation. 
2.1 FACTORS INFLUENCING THE DEVELOPMENT OF LYMPHEDEMA 
Several studies demonstrated that weight status (higher BMI) was associated with breast cancer-
related lymphedema in breast cancer survivors (Werner et al. 1991; Ozaslan et al. 2004). For 
example, the risk and severity of lymphedema were statistically associated with postoperative 
infection of the ipsilateral arm and BMI. Women with an infection and higher BMI are more 
likely to develop lymphedema and have a higher severity level of lymphedema (Soran et al. 
2006). The risk for arm lymphedema increased with increasing, BMI and women with BMI 
greater or equal than 30 had a 2.5-fold greater risk of arm lymphedema than lean women 
(Meeske et al. 2008). Overweight/obesity can be easily identified in breast cancer patients. Not 
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 only for breast cancer is it the risk factor but also for other health problems such as 
cardiovascular disease, diabetes, and other cancer-related diseases. Its poor healing and high 
infection rate may increase the risk and the severity of lymphedema. Weight management may 
be a potential intervention for those at greatest risk of lymphedema to maintain optimal health-
related quality of life among survivors (Paskett et al. 2007).  
According to information from the webpage of breast cancer organization, breast cancer 
survivors should avoid using excessively the operation-side arm in the prevention of 
lymphedema. Among reviewed studies, three indicated that the level of hand use is associated 
with the risk of lymphedema (Geller et al. 2003; Soran et al. 2006; Paskett et al. 2007). The types 
of jobs and activities and marriage status are potential factors that may interact with the level of 
hand use. The more frequently breast cancer patients use their arm from the treated side, the 
higher the risk that they get lymphedema. Soran et al. (2006) found that high level of hand use in 
one’s occupation such as construction worker, computer programmer, etc., is more likely to lead 
to lymphedema. Geller et al. (2003) found that women who work outside the home may use their 
arms more often and have higher risk of lymphedema than housewives. Paskett et al. (2007) also 
found that marriage status of breast cancer patients could result in higher risk of lymphedema 
formation because married women engage in more routine household chores and care of children 
compared with unmarried women. Table 1 shows predictive factors of lymphedema from 
reviewed publications. 
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 Table 1  Risk Factors Related to Lymphedema: Comparison of 5 Studies 
Risk Factors Study 
Soran et al. Geller et al. Goffman et al. Meeske et al. Paskett et al. 
Treatment-related factors      
ALND  ★    
Irradiation      
Chemotherapy  ★   ★ 
Disease-related factor      
Number of lymph node excised   ★ ★ ★ 
Tumor site/size      
Patient-related factors      
Age       ★(4)       ★(5)  
BMI ★  ★ ★ ★ 
Infection ★     
Hypertension    ★  
Frequency of hand use      ★(1)      ★(2)        ★(3) 
Note:  ★     Statistically significant 
(1) The level of hand use was defined as low, medium and high according to the patient’s job. 
(2) Patients work outside the home or not. (Yes/No) 
(3) Marriage status (married/single) 
(4) There was a significantly increased risk of lymphedema if women were under 50 years of age. 
(5) Younger age at diagnosis was associated with lymphedema. 
2.2 SENTINEL LYMPH NODE BIOPSY VS. AXILLARY LYMPH NODE 
DISSECTION 
That patients undergoing SNLB would decrease their risk of lymphedema relative to ALND  has 
been confirmed by many studies (Geller et al. 2003; Schijven et al. 2003; Goffman et al. 2004; 
Francis et al. 2006; Meeske et al. 2008). In the study of comparison of morbidity between ALND 
and SLNB (Schijven et al. 2003), SLNB is associated with less morbidity compared to ALND in 
patients with primary breast cancer. Patients having had SLNB had a 5-fold lower risk of 
lymphedema compared to patients having had ALND. Another study done by Francis et al. 
reported that the overall incidence of lymphedema was 16.8% after SLNB and 47.1% after 
ALND. There was a statistically significant difference in severity of lymphedema between 
SLNB and ALND (Francis et al. 2006). The time of onset of lymphedema after breast cancer 
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 treatment varies. It sometimes appears early and sometimes develops years later. A limited 
number of studies comparing the incidence of lymphedema between SLNB and ALND all have 
relatively short periods of follow-up time. Breast cancer patients still can possibly carry a risk for 
lymphedema for years even though they received SLNB instead of ALND. Therefore, long-term 
follow-up studies will yield more accurate assessment of the impact of SLNB in order to 
preventing breast cancer-related lymphedema (Soran et al. 2006). Since the major advantage of 
SLNB is that it may reduce lymphedema by decreasing the number of unnecessary ALND, the 
number of lymph nodes excised could be seen as a factor which is positively associated with 
lymphedema formation. Women who had 10 or more lymph nodes excised have a higher risk of 
lymphedema (Meeske et al. 2008). 
2.3 REVIEW OF THE RESULTS FROM THE SORAN ET AL. (2006) CASE-
CONTROL STUDY 
In 2006, Soran et al. published a paper in assessing potential risk factors associated with the 
development of breast cancer-related lymphedema. Patient/clinical factors (the level of hand use 
and infection), patient’s medical conditions (allergy, diabetes, hypertension, hypothyroidism, 
chronic obstructive pulmonary disease (COPD), and BMI), and disease-related factors (TNM 
stage, number of dissected nodes, number of positive nodes, and tumor size) were evaluated to 
find out significant predictors of lymphedema. The final results were that the statistically 
significant predictor variables were BMI, infection of the ipsilateral arm, and level of hand use. 
Table 2 shows parameter estimates of predictor variables (Soran et al. 2006). 
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 Table 2  Final Model Including Stratified Variables 
Variable 
Logistic Regression 
Coefficients OR (95% CI) p-value 
Infection 3.48 32.56 (6.45, 163.41) < 0.0001 
Occupation/hobby  
(level of hand use) 
Medium  0.77 2.16 (1.27, 3.68) 
0.0045 
High 1.54 4.67 (1.61, 13.50) 
BMI(centered)* 0.10 N/A 0.0153 
* BMI, Body Mass Index (kg/m2) 
2.4 LIMITATION 
In general, lymphedema does not occur in all breast cancer patients treated in a similar manner 
but risk does increase as a result of some of risk factors, such as obesity and radiation therapy. 
There is no perfect way to predict the risk of lymphedema because of anatomical variations in 
patient’s circulatory systems. It is not to be expected that any specific intervention could be 
adaptable to all breast cancer patients. However, a general predictive model for lymphedema still 
can be built to estimate the risk of lymphedema. For instance, a predicting tool for the need of 
complete ALND for breast cancer patients with sentinel lymph node (SLN) metastases has been 
developed at Memorial Sloan-Kettering Cancer Center (MSKCC) (Zee et al. 2003) by using a 
validated multivariate nomogram. The same prospective predicting system for lymphedema can 
be developed along the same lines as the MSKCC nomogram.  
10 
 3.0  METHODS 
3.1 PATIENT ACQUISITION 
Data were obtained from the previous study which was focusing on investigation of the 
significant predictors and how they affect the severity of lymphedema (Soran et al. 2006). A total 
of 2983 female patients having breast/axillary surgery were recruited at Magee-Women’s 
Hospital of University of Pittsburgh Medical Center between 1990 and 2000, but only 52 
patients with lymphedema had adequate data for the outcome (the severity of lymphedema). The 
Soran et al. study design was a 1:2 matched case-control study and data were analyzed on 104 
female control patients without lymphedema and 52 women with lymphedema. Our current 
study included the same 52 cases but included all 126 available controls matched on age, 
radiation therapy, and type of operation from the previous study.  
3.2 STATISTICAL ANALYSIS 
N:M matching was performed so that there is a varying number of cases and controls in the 
matched sets. A total of 178 patients (52 cases and 126 controls) were matched on age (<45, 46-
54, 55-64, >65), radiation therapy (yes/no), and type of operation (Segmental Mastectomy, 
Modified Radical Mastectomy, and Modified Radical Mastectomy with TRAM) and categorized 
11 
 into 24 N:M matched sets. If any case patients or control patients relating to a matched set were 
missing, the matched set was excluded from the analysis. A patient’s BMI was recorded as a 
categorical variable by using a cut-off value 25 kg/m2. The SAS System® (SAS Institute Inc, 
Cary, NC) version 9.1 was used for analysis. 
3.2.1 Lymphedema probability estimation 
3.2.1.1 Estimated probabilities from a case-control study 
Suppose there are J combinations of major risk factors to cause lymphedema, where Cj is one of 
those combinations, j = 1, 2…J.  Table 3 shows how the numbers of cases and controls could be 
displayed for each risk factor combination. 
 
Table 3  Numbers of Cases and Controls for Each Combination 
j Cj # cases # controls 
1 
2 
. 
. 
. 
J 
1C  
2C  
. 
. 
. 
JC  
1n  
2n  
. 
. 
. 
Jn  
1m  
2m  
. 
. 
. 
Jm  
Total N=52 M=126 
 
 
Three major risk factors, BMI (<25kg/m2, 25kg/m2), infection (yes/no), and 
occupational hand use (low, medium, and high), formed 12 combinations. Therefore, the 
probability of a combination of risk factors given lymphedema cases (y = 1) or non-lymphedema 
controls (y = 0) could be shown by: 
≥
12 
  
( ) ( )| 1 ( )jj n number of cases in jth combinationP C y N total number of cases= =  where j = 1,2,…12 
( ) ( )| 0 ( )jj m number of controls in jth combinationP C y M total number of controls= =  
3.2.1.2 Incidence of lymphedema 
The incidence of lymphedema, P(LE), could be obtained from a single study. Although the 
reported incidence of lymphedema after breast cancer therapy varies across treatments, Lin et al. 
(1993) was chosen to be the reference because it utilized breast cancer therapy, follow-up time, 
and a definition of lymphedema measurement that were consistent with our study. They reported 
that the incidence of lymphedema was present in 16% of the members of 122 patients for 
evaluation of morbidity due to ALND in two-year follow-up. Table 4 shows the overall 
incidence of lymphedema in subgroups. 
 
Table 4  Lymphedema from ALND (Lin et al. 1993) 
Lymphedema % No. 
≥  2 cm 16.00 19/122 
≥  3 cm 6.00 07/122 
≥  4 cm 2.00 02/122 
 
3.2.1.3 Using Bayes’ Theorem to estimate the lymphedema probability 
Since the outcome probability conditioning on exposures could not be estimated through case-
control studies, Bayes’ Theorem used to solve this problem. This approach utilizes the 
13 
 conditional and marginal probabilities of lymphedema ( 1y = ), non-lymphedema ( ) and a 
combination of lymphedema risk factors (
0y =
jC ). 
The lymphedema probability conditioning on a combination of risk factors could be 
estimated by using the equation listed below: 
 
( ) ( )
( ) ( )
( )
( ) ( )
( ) ( ) ( ) ( )
1,
1|
( )
| 1 1
| 1 1
| 1 1 | 0 0
j
j
j
j
j
j
j j
P y C
P y C
P C
P C y P y
P C
P C y P y
P C y P y P C y P y
== =
= ==
= == = = + = =
 
3.2.2 Variance estimation 
After calculating the estimated lymphedema probability, its variance could be estimated by the 
delta method. It is a method for deriving an approximate probability distribution for a function of 
an asymptotically normal statistical estimator from knowledge of the limiting variance of that 
estimator. Basically, the approximate estimated variance is similarly obtained by expanding in a 
Taylor series and retaining only second-order terms(Mood et al. 1974).  
The numbers of cases and controls in each risk factor combination follow a multinomial 
distribution. For cases, ( )1~ ,j jC Multinomial N p and, for controls, ( )2~ ,j jC Multinomial M p . 
The incidence of lymphedema was estimated from a single study and it would follow a binomial 
14 
 distribution, , Y being the number of breast cancer patients with lymphedema 
and n being the number of patients in the source study. The probability of 
(Y Binomial n p~ ),
jC , and Y would be 
asymptotic normality of the multinomial distribution: 
P C y N p
p p
Nj j
j j( | ) ~ ( ,
( )
)= −1 11 1 1     
P C y N p
p p
Mj j
j j( | ) ~ ( ,
( )
)= −0 12 2 2  
P Y N p p p
N M
( ) ~ ( , ( ) )1−+  
The estimated probability of lymphedema given risk factors would be rewritten as the 
following formula according to the Bayes’ Theorem: 
$ $ $$ $ $ ( $ )p
p p
p p p p
a c
a c b c
= + −1  
The general form of the delta method for the variance of pˆ  is : (Mood et al. 1974) 
( ) ( ) ( ) ( )
( ) ( ) ( )
2 2 2
ˆ ˆ ˆˆ ˆ ˆ ˆ
ˆ ˆ ˆ
ˆ ˆ ˆ ˆ ˆ ˆˆ ˆ ˆ ˆ ˆb cˆ2 , 2 , 2 ,ˆ ˆ ˆ ˆ ˆ ˆ
a b c
a b c
a b a c
a b a c b c
p p pVar p Var p Var p Var p
p p p
p p p p p pCov p p Cov p p Cov p p
p p p p p p
⎧ ⎫ ⎧ ⎫ ⎧ ⎫∂ ∂ ∂= + +⎨ ⎬ ⎨ ⎬ ⎨ ⎬∂ ∂ ∂⎩ ⎭ ⎩ ⎭ ⎩ ⎭
⎧ ⎫ ⎧ ⎫ ⎧ ⎫∂ ∂ ∂ ∂ ∂ ∂+ ⋅ + ⋅ ⋅⎨ ⎬ ⎨ ⎬ ⎨ ⎬∂ ∂ ∂ ∂ ∂ ∂⎩ ⎭ ⎩ ⎭ ⎩ ⎭
+
 
The partial derivatives of with respect to , and are: $p $ , $p pa b $pc
[ ]
∂
∂
$
$
$ $ ( $ )
$ $ $ ( $
p
p
p p p
p p p pa
b c c
a c b c
= −+ −
1
1 2
 
[ ]
∂
∂
$
$
$ $ ( $ )
$ $ $ ( $
p
p
p p p
p p p pb
a c c
a c b c
= −+ −
1
1 2
 
[ ]
∂
∂
$
$
$ $
$ $ $ ( $
p
p
p p
p p p pc
a b
a c b c
= + −1 2  
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 Since ˆ ˆ,a bp p and ˆcp are independent, the delta method gives: 
( ) ( ) ( ) ( )
2 2
ˆ ˆˆ ˆ ˆ ˆ
ˆ ˆa b ca b
2
ˆ
ˆc
p p pVar p Var p Var p Var p
p p p
⎧ ⎫ ⎧ ⎫ ⎧ ⎫∂ ∂= + +⎨ ⎬ ⎨ ⎬ ⎨ ⎬∂ ∂⎩ ⎭ ⎩ ⎭ ⎩ ⎭
∂
∂  
The delta method is an important general technique for calculating asymptotic 
distributions and thereby deducing asymptotic means, variances, and covariances (Bishop et al. 
1975). Since this study uses multivariate version of the delta method, the following theorem 
shows the asymptotically normal distribution for a T-dimensional random vector. 
Let nˆθ is a T-dimensional random vector, ( )1ˆ ˆ ˆ,...n n nTθ θ θ=  and θ is a T-dimensional vector 
parameter, ( 1,... T )θ θ θ= . nˆθ has an asymptotic normal distribution in the sense that  
( ) ( )ˆ (0, )nn Nθ θ θ⎡ ⎤− →⎣ ⎦ ∑l  
( )θ∑ is the T x T asymptotic covariance matrix of nˆθ and is a singular covariance matrix if 
nˆθ has a distribution that is concentrated on a subspace of three-dimensional space. nˆθ has an 
approximate ( )1( , )N nθ θ− ∑ distribution.  
Suppose f is a function defined on an open subset of T-dimensional space and taking 
values in R-dimensional space, i.e., 
( ) ( )1( ),..., ( )Rf f fθ θ θ= . 
 Assuming that f has a differential atθ , ( )f x can be expressed in matrix notation as: 
( ) ( ) ( )( ) ff x f x o xθ θ θθ
′∂⎛ ⎞= + − + −⎜ ⎟∂⎝ ⎠  
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 Then the asymptotic distribution of ( )nˆf θ is given by:  
( ) ( )ˆ( ) ( ) (0, )n f fn f f N pθ θ θ θ ′∂ ∂⎛ ⎞ ⎛ ⎞⎡ ⎤− → ⎜ ⎟ ⎜ ⎟⎣ ⎦ ∂ ∂⎝ ⎠ ⎝ ⎠∑l   
Because phat would be approximately following a normal distribution, the 95% confidence 
interval of the predicted probability was estimated using the normal approximation: 
( )
1
2
ˆ ˆp Z Var pα−±  
Finally, the delta method provides a means of assessing the relative contributions of pa, pb 
and pc to the variance of p. One can examine the variances and their coefficients to assess the 
greatest contribution to the overall variance estimate. A particularly large variance or coefficient 
would indicate when a substantial contribution to ( )ˆVar p comes from. The implication would be 
that reducing could focus first on reducing the large variance or the variance associated 
with the large coefficient. Different estimates of the lymphedema incidence rate were chosen 
from published papers, and the sensitivity of lymphedema probabilities based on them would be 
discussed as well. 
( )ˆVar p
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 4.0  RESULTS 
4.1 THE RISK OF LYMPHEDEMA UNDER MAJOR RISK FACTORS 
Table 5 shows lymphedema predictions among 8 risk factor combinations. They were 
estimated by using the incidence rate of lymphedema of 16%. One case patient was excluded 
because of missing information of BMI and infection. Patients who were in combinations 4, 7, 
and 8 would have higher risk of lymphedema. The highest estimated lymphedema probability 
was 0.7671 (95% CI 0.3904 to 1.0000) for breast cancer patients with BMI≥ 25kg/m2, infection, 
and medium/high level of hand use. Breast cancer patients having their BMI < 25kg/m2, 
infection, and frequently using their hands would have 58.54% (95% CI 0.0331 to 1.0000) risk 
of lymphedema after surgery. That predicted probability was higher than the 48.49% (95% CI 
0.0568 to 0.9129) of those who had infection, higher BMI but low level of hand use. It is obvious 
that the level of occupational hand use would be a more sensitive predictor than BMI to cause 
lymphedema formation.  
Table 6 shows variances and their coefficients to assess propagation of error in the delta 
method. All variances of case probability (pa), control probability (pb), and incidence of 
lymphedema (pc) are small enough in each combination but the coefficients of pa and pb in 
combination 4, 7 and 8 are much larger than the others. That means when estimating the overall 
18 
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variance of lymphedema probability in combinations 4, 7 and 8, variances of pa and pb should be 
lower down to compensate for their large coefficients.  
  
Table 5  Prediction Probabilities of Lymphedema for Patients with Combinations of the Significant Factors 
set Risk factors combination # cases Case Prob. 
# 
controls 
Control 
Prob. 
Estimated 
LE prob. 
Variance 
of 
LE prob. 
95% C.I. of LE 
1 
BMI < 25 
No infection 
Low level of hand use 
5 0.0980 32 0.2540 0.0685 0.0010 (0.0065, 0.1305) 
2 
BMI < 25 
No infection 
Medium / high level of hand use 
10 0.1961 18 0.1429 0.2073 0.0046 (0.0745, 0.3401) 
3 
BMI < 25 
Infection 
Low level of hand use 
N/A N/A 1 0.0079 N/A N/A N/A 
4 
BMI < 25 
Infection 
Medium / high level of hand use 
3 0.0588 1 0.0079 0.5854 0.0794 (0.0331, 1.0000) 
5 
BMI 25 ≥
No infection 
Low level of hand use 
8 0.1569 52 0.4127 0.0675 0.0006 (0.0184, 0.1167) 
6 
BMI 25 ≥
No infection  
Medium / high level of hand use ≥
14 0.2745 19 0.1508 0.2575 0.0051 (0.1180, 0.3970) 
7 
BMI 25 
Infection 
Low level of hand use ≥
4 0.0784 2 0.0159 0.4849 0.0477 (0.0568, 0.9129) 
8 
BMI 25 
Infection 
Medium / high level of hand use 
7 0.1373 1 0.0079 0.7671 0.0369 (0.3904, 1.0000) 
Total 51 1.0000 126 1.0000    
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pset Risk factors combination Estimated LE prob. 
Variance 
of 
LE prob. 
pa b 
Var(pa) 
(Coeff_pa) 
Var(pb) 
(Coeff_pb) 
Var(pc) 
(Coeff_pc) 
95% C.I. of LE 
1 
BMI < 25 
No infection 
Low level of hand use 
0.0685 0.0010 0.0980 0.2540 0.0017 (0.4325) 
0.0015 
(0.0630) 
0.0008 
(0.2254) (0.0065, 0.1305) 
2 
BMI < 25 
No infection 
Medium / high level of hand use 
0.2073 0.0046 0.1961 0.1429 0.0031 (0.7021) 
0.0010 
(1.3230) 
0.0008 
(1.4944) (0.0745, 0.3401) 
3 
BMI < 25 
Infection 
Low level of hand use 
N/A N/A N/A 0.0079 N/A (N/A) 
0.0001 
(N/A) 
0.0008 
(N/A) N/A 
4 
BMI < 25 
Infection 
Medium / high level of hand use 
0.5854 0.0794 0.0588 0.0079 0.0011 (17.0248) 
0.0001 
(935.246) 
0.0008 
(3.2613) (0.0331, 1.0000) 
5 
BMI 25 ≥
No infection 
Low level of hand use 
0.0675 0.0006 0.1569 0.4127 0.0026 (0.1611) 
0.0019 
(0.0230) 
0.0008 
(0.2194) (0.0184, 0.1167) 
6 
BMI 25 ≥
No infection  
Medium / high level of hand use  ≥
0.2575 0.0051 0.2745 0.1508 0.0039 (0.4850) 
0.0010 
(1.6070) 
0.0008 
(2.0234) (0.1180, 0.3970) 
7 
BMI 25 
Infection 
Low level of hand use ≥
0.4849 0.0477 0.0784 0.0159 0.0014 (10.1415) 
0.0001 
(247.6070) 
0.0008 
(3.4537) (0.0568, 0.9129) 
8 
BMI 25 
Infection 
Medium / high level of hand use 
0.7671 0.0369 0.1373 0.0079 0.0023 (1.6941) 
0.0001 
(506.6680) 
0.0008 
(1.7668) (0.3904, 1.0000) 
Table 6  Variances and Their Coefficients in the Delta Method 
 Table 7 shows the comparison of lymphedema incidence among several published papers. 
The incidences range from 16% to 46.3% depending on the definition of lymphedema used, the 
method of measurement, the length of follow-up, and the choice of therapy in each independent 
study.  
Table 7  Incidence of Lymphedema in Published Series 
Year Study Type of Surgery LE definition Follow-up 
No. 
patients 
LE 
incidence 
1986 Kissin et al.(1) N/A ≧2cm 9 months 200 25.5% 
1991 Werner et al. (2) ALND, RT ≧2.5 cm 37 months 282 19.5% 
1993 Lin et al. (3) 
RM, MRM  
Lumpectomy with ALND 
Irradiation 
≧2cm 2 years 283 16% 
1993 
Keramopoulos  
et al. (4) 
SM/MRM 
ALND 
≧2cm 6 months 104 17% 
2003 Deutsch et al. (5) 
RM 
Mastectomy+Radiotherapy 
Mastectomy alone  
≧2cm 3 years 1665 46.3% 
2005 Clark et al. (6) 
Mastectomy 
Wide local excision 
Lumpectomy 
PVD ≧20% 
aPVD_change
≧5% 
3 years 188 20.7% 
Note:  LE: Lymphedema; RT: Radiation Therapy; RM: Radical Mastectomy; SM: Segmental Mastectomy; MRM: Modified Radical Mastectomy 
(1)  (Kissin et al. 1986)  (2)  (Werner et al. 1991)  (3)  (Lin et al. 1993)  (4)  (Keramopoulos et al. 1993) 
(5)  (Deutsch et al. 2003)  (6)  (Clark et al. 2005) 
 
Table 8 summarizes the comparison of estimated probabilities by different incidence of 
lymphedema from 16% to 46.3%. For the combination of BMI 25, infection, and medium/high 
level of hand use, the probabilities estimated among five different incidence of lymphedema 
were much higher than other risk factor combinations. The estimated probability would follow a 
trend by increasing of lymphedema incidence. 
≥
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 Table 8  Comparison of Lymphedema Probabilities 
Set Risk factors combination 
Estimated LE probabilities  
By different incidence of Lymphedema 
16% 17% 19.5% 20.7% 25.5% 46.3% 
1 
BMI < 25 
No infection 
low level of hand use 
0.0685 0.0733 0.0855 0.0915 0.1167 0.2497 
2 
BMI < 25 
No infection 
medium / high level of hand use 
0.2073 0.2194 0.2495 0.2638 0.3196 0.5420 
3 
BMI < 25 
Infection 
low level of hand use 
N/A N/A N/A N/A N/A N/A 
4 
BMI < 25 
Infection  
medium / high level of hand use 
0.5854 0.6029 0.6423 0.6593 0.7173 0.8647 
5 
BMI 25 ≥
No infection 
low level of hand use 
0.0675 0.0722 0.0843 0.0903 0.1151 0.2468 
6 
BMI 25 ≥
No infection  
medium / high level of hand use  
0.2575 0.2716 0.3060 0.3221 0.3884 0.6108 
7 
BMI 25 ≥
Infection 
low level of hand use 
0.4849 0.5030 0.5448 0.5633 0.6284 0.8099 
8 
BMI 25 ≥
Infection  
medium / high level of hand use 
0.7671 0.7798 0.8073 0.8187 0.8555 0.9372 
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Figure 1  Estimated Lymphedema Probability by Incidence of Lymphedema 
Figure 1 presents the estimated lymphedema probabilities by comparing different lymphedema 
incidence rates in each risk factor combination. The lines for combinations 1 and 5 are almost 
merged. The difference between these two risk factor combinations is the category of patient’s 
BMI. The estimated lymphedema probabilities in combination 5 (BMI≥ 25kg/m2) were less than 
those estimated in combination 1 (BMI<25 kg/m2). When BMI was grouped by cutoff 25kg/m2, 
it would not influence the estimated lymphedema probability. Patients in combinations 4, 7 and 8 
had higher estimated lymphedema probabilities than those in other combinations. Although the 
estimated probabilities in all combinations increased from 16% to 46.3% of the lymphedema 
incidence, it is important to detect how sensitive the estimated probabilities were to different 
lymphedema incidence rates.  
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Figure 2  The Difference of the Estimated Lymphedema Probabilities 
The percentage change of lymphedema probability was calculated based on the previous 
incidence. Figure 2 presents the percentage change of the estimated lymphedema probabilities by 
comparing different lymphedema incidence rates in each risk factor combination. When an 
incidence jumped into 46.3%, a greater percentage increase was revealed, especially in 
combinations 1 and 5. Higher estimated lymphedema probabilities correlated to less percentage 
change in different incidence rates. Patients in combination 8 had much higher lymphedema 
probability than patients who were in other combinations; and combination 8 also showed less 
variability because it had a flat and smooth line of depicting each percentage difference of 
lymphedema probabilities between two of incidence values. Overall, the estimated probabilities 
in combination 8 were relatively insensitive to changes in incidence values between 17% and 
25.5%.  
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 5.0  DISCUSSION 
The purpose of this study was to estimate lymphedema probability after breast cancer surgery by 
three confirmed risk factors (BMI, Infection, and Occupational/hobby hand use) and to assess its 
variability in predicting lymphedema. Our finding indicated that patients who had their BMI 
greater than 25kg/m2, infection, and medium/high level occupational/hobby hand use would 
significantly have high risk of lymphedema after breast cancer surgery. The predicted probability 
varied from 77% to 94%, depending on which incidence rate was used. 
Our study used 16% of lymphedema incidence rate to estimate probabilities because this 
incidence rate was utilized by breast cancer surgery, follow-up time, and a definition of 
lymphedema measurement which were consistent with our study. The 95% confidence interval 
for the predicted lymphedema probability was estimated in each risk factor combination. The 
results show that estimated lymphedema probabilities in combinations 4 and 7 were higher and 
had much wider 95% CI (0.2018 to 1.0000; 0.1853 to 1.0000) than probabilities in other 
combinations. The highest estimated probability was shown in combination 8 and it had a fairly 
wide 95% CI (0.5516 to 1.0000). In contrast, the lowest lymphedema probability shown in 
combination 5 had the narrowest 95% CI (0.0327 to 0.1707). Therefore, it indicated that better 
prediction of lymphedema revealed in combinations with low estimated probabilities but 
combinations with high estimated probabilities did not predict lymphedema as well. 
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 Swelling may occur at any point following axillary node dissection or radiation therapy, 
beginning immediately after or even delayed by several years (Paskett et al. 2007). In the 
literature, a broad range of incidence rates of post-operative lymphedema varies widely from 8% 
to 49% in ALND patients. In this study, 16% to 46.3% incidence rate was used with assessment 
of lymphedema probabilities. Approximately 15% to 20% of breast cancer patients develop 
lymphedema following breast cancer treatment (Petrek et al. 2000). Our study revealed 
lymphedema probabilities estimated between 19.5% and 20.7% of lymphedema incidences being 
similar among breast cancer patients in each risk factor combination.  
 We found that the predicted lymphedema probabilities for patients in combination 8 were 
insensitive to different lymphedema incidence rates. These predicted probabilities did not have a 
huge difference along incidence rates increased. However, the predicted lymphedema 
probabilities in combinations 1 and 5 were sensitive to incidence rates. Especially when 
lymphedema incidence changed to 46.3%, the estimated probabilities in these two combinations 
would increase tremendously. We could conclude that no matter how large we used the 
lymphedema incidence rate to estimate probabilities, breast cancer patients with their BMI 
greater than 25kg/m2, infection, and high/medium level of hand use would have pretty stable risk 
of lymphedema than those who have other risk factor combinations. 
 Even though we found that high estimated lymphedema probabilities occurred in 
combinations 4, 7 and 8, the method of propagation of error indicated that these combinations 
were associated with high coefficients estimated by the delta method. If we plan to use these 
combinations of risk factor to estimate lymphedema probabilities, we should find a way to lower 
their coefficients or reduce the associated variances in order to improve the overall variance 
estimates of lymphedema probability.  
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  This model represents a significant improvement over estimates based on three risk 
factors but it is limited by the small number of patients on which it was based. Furthermore, the 
model remains to be tested on a larger group of patients. Another limitation is the fact that the 
controls were sampled to match cases. They could therefore not be considered a random sample 
of the control population. It is possible for a reason that pb is biased. Nevertheless, for breast 
cancer survivors, this nomogram was studied to provide a risk estimate that can help them for an 
early prevention of lymphedema. The public health importance of this study is to determine 
what, if any, factors contribute to an increased risk of lymphedema as well as to establish which 
subgroups of patients are at increased risk. Once the factors that influence the development of 
lymphedema are clarified, such findings can be used to develop preventive measures. 
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 APPENDIX A 
DATA SET DESCRIPTION 
Table A. 1  Patient’s Occupation Codes 
Patient’s Occupation 
1 2 3 
Continous, <1/2h + <8h/day Continous, 1/2-1h + <8h/day Continous, >1h + at least 8h/day 
None Bank teller Flight attendant 
Retired Secretary Phys lab tester 
Homemaker Medical secretary Nurse 
Travel consultant Receptionist Registered nurse 
Teller School teacher Nursing instructor 
Sales Speech language specialist Computer operator 
Sales representative Teacher Aide Physician 
Buyer consolidation School nurse AGH 
Sales adm coordinator Dental assistant Surg tech. 
Pbx supervisor Travel agent Laborer 
Merchandise manager Accounting Pianist 
Office manager Sales assistant Piano teacher 
Clerk Marketing Waitress 
Counselor School bus driver  
Administrator Cook  
Auditor professor  
Self employed Dietary Aide  
Recruiter   
Attorney   
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 APPENDIX B 
APPLIED SAS PROCEDURES AND OUTPUT 
/***Read the LE dataset, code BMI and occup. hand use as dummy variables, and  
define 12 groups of risk factor combination***/ 
option nodate pageno = 1; 
data matchset; 
 infile 'G:\analysis\0506.txt'; 
 input Set 1-2 LEcase 4 Agegr$ 6-10 Operation$ 12-19 RT$ 22 BMI 24-25 
Infection 27 Occup 29; 
 if Occup = 2 then Doccup_1 = 1 else Doccup_1 = 0 ; ; 
 if Occup = 3 then Doccup_2 = 1;else Doccup_2 = 0; 
 if BMI ge 25 then DBMI_1 = 1; else DBMI_1 = 0; 
 if BMI = ' then DBMI_1 = '.';  '.
 if BMI < 25 and Infection = 0 and Occup = 1 then CovarSet = 1; 
 if BMI < 25 and Infection = 0 and Occup = 2 then CovarSet = 2; 
 if BMI < 25 and Infection = 0 3 then CovarSet = 3 and Occup =  ; 
 if BMI < 25 and Infection = 1 and Occup = 1 then CovarSet = 4; 
 if BMI < 25 and Infection = 1 and Occup = 2 then CovarSet = 5; 
 if BMI < 25 and Infection = 1 nd Occup = 3  CovarSet = 6  a  then ; 
 if BMI ge 25 and Infection = 0 and Occup = 1 then CovarSet = 7; 
 if BMI ge 25 and Infection = 0 and Occup = 2 then CovarSet = 8; 
 if BMI ge 25 and Infection = 0 and Occup = 3 then CovarSet = 9; 
 if BMI ge 25 and Infection = 1 and Occup = 1 then CovarSet = 10; 
 if BMI ge 25 and Infection = 1 and Occup = 2 then CovarSet = 11; 
 if BMI ge 25 and Infection = 1 and Occup = 3 then CovarSet = 12; 
 obs +1; 
run; 
 
title1 'Matched Dataset'; 
proc print data = matchset; 
run; 
 
data cases; 
 set matchset; 
 if LEcase = 1; 
run; 
proc sort data=cases; 
 by CovarSet; 
run; 
 
data controls; 
 set matchset; 
 if LEcase = 0; 
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 run; 
proc sort data=controls; 
 by CovarSet; 
run; 
 
title1 'Frequency table for Cases'; 
proc freq data = cases; 
 table DBMI_1 Infection Occup; 
run; 
title1 'Frequency table for Controls'; 
proc freq data = controls; 
 table  DBMI_1 Infection Occup; 
run; 
 
proc univariate data=cases noprint; 
 by CovarSet; 
 var Occup; 
 output out = casecounts n   = total_case; 
run; 
proc univariate data = controls noprint; 
 by CovarSet; 
 var Occup; 
 output out = contcounts n = total_control; 
run; 
 
data summary; 
 merge casecounts contcounts; 
 caseprobs = total_case/52; 
 contprobs = total_control/126; 
 by CovarSet; 
run; 
proc print data = summary; 
 title1 'Case and Control Conditional Probabilities by Covariate 
Combination'; 
run; 
title; 
 
data temp; 
 set matchset; 
 if LEcase = '.' then delete; 
run; 
pattern1 v=s c=black; 
pattern2 v=x2; 
axis1 label = ('BMI') value = ( ' < 25'  ' > = 25'); 
axis  label2  = ('Lymphedema') value = ('No' 'Yes'); 
proc gchart data = temp; 
 hbar DBMI_1/ discrete type = freq  patternid = group  group = LEcase 
 maxis = axis1 gaxis = axis2; 
 title 'Bar chart for categorical BMI grouped by cases and controls'; 
run; 
quit; 
title; 
 
/***combine medium and high level of hand use together to be one 
combination***/  
data combined; 
 set summary; 
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  if CovarSet in (2,3) then ind = 2; 
 else if CovarSet in (5,6) then ind = 4; 
 else if CovarSet in (8,9) then ind = 6; 
 else if CovarSet in (11,12) then ind = 8; 
 if CovarSet = ' then delete; '.
 if CovarSet = 1 then ind = 1; 
 if CovarSet = 4 then ind = 3; 
 if CovarSet = 7 then ind = 5; 
 if CovarS 10 then ind = 7;et =   
 if obs = 2|4|6|8 then count = 1; 
 else if count = 0; 
run; 
proc sort data = combined;  
 by ind; 
run  ;
proc sql; 
 create table test1 as 
 select CovarSet, ind, total_case, total_control, sum(total_case) as 
case, sum(total_control) as control  
 from combined(where=(ind eq 2|ind eq 4|ind eq 6|ind eq 8)) 
 group by ind 
 union select CovarSet, ind, total_case, total_control, total_case as 
case, 
 total_control as control from combined(where=(ind eq 1|ind eq 3|ind eq 
5|ind eq 7)); 
quit; 
proc print data = test1; 
 var ind case control; 
run; 
 
data case_control; 
 set test1; 
  caseprobs = case/51; 
  contprobs = control/126; 
%macro LEstudy(p_LE=); 
  phat = (caseprobs*&p_LE.)/(caseprobs*&p_LE. + contprobs*(1-
&p_LE.)); 
  dp1 = (contprobs*&p_LE.*(1 - &p_LE.)) / (caseprobs*&p_LE. + 
contprobs* (1-&p_LE.))**2; 
  dp2 = (caseprobs*&p_LE.*(&p_LE. - 1)) / (caseprobs*&p_LE. + 
contprobs* (1-&p_LE.))**2; 
  dp3 = (caseprobs*contprobs) / (caseprobs*&p_LE. + contprobs* (1-
&p_LE.))**2; 
  Var_p1 = caseprobs*(1-caseprobs)/ 51; 
  Var_p2 = contprobs*(1-contprobs)/ 126; 
  Var_p3 = &p_LE.*(1-&p_LE.)/177; 
  Var_phat = Var_p1*(dp1)**2 + Var_p2*(dp2)**2 + Var_p3*(dp3)**2; 
  phat_lower = phat - 1.96*Var_phat**0.5; 
  phat_upper = phat + 1.96*Var_phat**0.5; 
  if phat_lower < 0 then phat_lower = 0; 
  if phat_upper > 1 then phat_upper = 1; 
run; 
proc print data = case_control; 
 var ind caseprobs contprobs phat Var_phat phat_lower phat_upper; 
run; 
quit; 
%mend LEstudy; 
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 title1 'Estimated lymphedema probability by using 16% incidence of 
lymphedema'; 
 %LEstudy (p_LE = 0.16); 
title1 'Estimated lymphedema probability by using 17% incidence of 
lymphedema'; 
 %LEstudy( p_LE = 0.17); 
title1 'Estimated lymphedema probability by using 19.5% incidence of 
lymphedema'; 
 %LEstudy (p_LE = 0.195); 
title1 'Estimated lymphedema probability by using 20.7% incidence of 
lymphedema'; 
 %LEstudy (p_LE = 0.207); 
title1 'Estimated lymphedema probability by using 25.5% incidence of 
lymphedema'; 
 %LEstudy (p_LE = 0.255); 
title1 'Estimated lymphedema probability by using 49% incidence of 
lymphedema'; 
 %LEstudy (p_LE = 0.463); 
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 Conditional Logistic Regression                               
 
                                    The LOGISTIC Procedure 
 
                                     Conditional Analysis 
 
                                       Model Information 
 
                    Data Set                           WORK.MATCHSET 
                    Response Variable                  LEcase 
                    Number of Response Levels          2 
                    Number of Strata                   21 
                    Number of Uninformative Strata     5 
                    Frequency Uninformative            14 
                    Model                              binary logit 
                    Optimization Technique             Newton-Raphson ridge 
 
 
                            Number of Observations Read         181 
                            Number of Observations Used         173 
 
 
                                        Response Profile 
 
                               Ordered                      Total 
                                 Value       LEcase     Frequency 
 
                                     1            0           125 
                                     2            1            48 
 
                               Probability modeled is LEcase=1. 
 
NOTE: 8 observations were deleted due to missing values for the response, explanatory, or 
      strata  variables. 
 
 
                                      Strata Information 
 
                                                            LEcase 
                                                Stratum    -------- 
                            Stratum    Set    Frequency     0     1 
 
                                  1      1            3     2     1 
                                  2      2            4     3     1 
                                  3      3            4     2     2 
                                  4      4            2     2     0 
                                  5      5           19    11     8 
                                  6      6           22    15     7 
                                  7      7           31    23     8 
                                  8      8           11     7     4 
                                  9      9            9     9     0 
                                 10     10            5     4     1 
                                 11     11            8     6     2 
                                 12     12            4     3     1 
                                 13     13            9     7     2 
                                 14     14           11    10     1 
                                 15     15           13     8     5 
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                                Conditional Logistic Regression                               
 
                                    The LOGISTIC Procedure 
 
                                     Conditional Analysis 
 
                                     Odds Ratio Estimates 
 
                                         Point          95% Wald 
                         Effect       Estimate      Confidence Limits 
 
                         DBMI_1          1.861       0.640       5.411 
                         Infection      11.953       2.376      60.124 
                         Doccup_1        1.788       0.535       5.976 
                         Doccup_2       27.372       7.876      95.129 
 
 
 
Case and Control Conditional Probabilities by Covariate Combination             
 
                         Covar    total_     total_ 
                  Obs     Set      case     control    caseprobs    contprobs 
 
                    1       .        1          .       0.01923       . 
                    2       1        5         32       0.09615      0.25397 
                    3       2        .         12        .           0.09524 
                    4       3       10          6       0.19231      0.04762 
                    5       4        .          1        .           0.00794 
                    6       5        1          1       0.01923      0.00794 
                    7       6        2          .       0.03846       . 
                    8       7        8         52       0.15385      0.41270 
                    9       8        5         17       0.09615      0.13492 
                   10       9        9          2       0.17308      0.01587 
                   11      10        4          2       0.07692      0.01587 
                   12      11        1          1       0.01923      0.00794 
                   13      12        6          .       0.11538       . 
 
 
Estimated lymphedema probability by using 16% incidence of lymphedema 
 
    Obs    ind    caseprobs    contprobs      phat     Var_phat        Var_p1        Var_p2 
 
      1     1      0.09804      0.25397     0.06849    0.001000    .001733873    .001503717 
      2     2      0.19608      0.14286     0.20725    0.004590    .003090817    .000971817 
      3     2      0.19608      0.14286     0.20725    0.004590    .003090817    .000971817 
      4     3       .           0.00794      .          .          .             .000062488 
      5     4      0.05882      0.00794     0.58537    0.079400    .001085555    .000062488 
      6     4      0.05882      0.00794     0.58537    0.079400    .001085555    .000062488 
      7     5      0.15686      0.41270     0.06751    0.000629    .002593271    .001923638 
      8     6      0.27451      0.15079     0.25747    0.005064    .003904984    .001016309 
      9     6      0.27451      0.15079     0.25747    0.005064    .003904984    .001016309 
     10     7      0.07843      0.01587     0.48485    0.047693    .001417253    .000123977 
     11     8      0.13725      0.00794     0.76712    0.036936    .002321882    .000062488 
     12     8      0.13725      0.00794     0.76712    0.036936    .002321882    .000062488 
 
35 
                                                            phat_      phat_ 
    Obs      Var_p3      sqr_dp1    sqr_dp2    sqr_dp3     lower      upper 
 
      1    .000759322     0.4235      0.063    0.22536    0.00650    0.13048 
      2    .000759322     0.7021      1.323    1.49443    0.07446    0.34005 
      3    .000759322     0.7021      1.323    1.49443    0.07446    0.34005 
      4    .000759322      .           .        .         0.00000     . 
      5    .000759322    17.0248    935.246    3.26127    0.03308    1.00000 
      6    .000759322    17.0248    935.246    3.26127    0.03308    1.00000 
      7    .000759322     0.1611      0.023    0.21940    0.01835    0.11667 
      8    .000759322     0.4850      1.607    2.02342    0.11799    0.39695 
      9    .000759322     0.4850      1.607    2.02342    0.11799    0.39695 
     10    .000759322    10.1415    247.607    3.45369    0.05681    0.91289 
     11    .000759322     1.6941    506.668    1.76679    0.39044    1.00000 
     12    .000759322     1.6941    506.668    1.76679    0.39044    1.00000 
 
 
Estimated lymphedema probability by using 17% incidence of lymphedema 
 
                                                                       phat_      phat_ 
       Obs    ind    caseprobs    contprobs      phat     Var_phat     lower      upper 
 
         1     1      0.09804      0.25397     0.07327    0.001124    0.00756    0.13898 
         2     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         3     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         4     3       .           0.00794      .          .          0.00000     . 
         5     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         6     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         7     5      0.15686      0.41270     0.07223    0.000704    0.02023    0.12422 
         8     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
         9     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
        10     7      0.07843      0.01587     0.50299    0.047653    0.07514    0.93085 
        11     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
        12     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
 
 
 
 
            Estimated lymphedema probability by using 19.5% incidence of lymphedema           
 
                                                                       phat_      phat_ 
       Obs    ind    caseprobs    contprobs      phat     Var_phat     lower      upper 
 
         1     1      0.09804      0.25397     0.07327    0.001124    0.00756    0.13898 
         2     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         3     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         4     3       .           0.00794      .          .          0.00000     . 
         5     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         6     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         7     5      0.15686      0.41270     0.07223    0.000704    0.02023    0.12422 
         8     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
         9     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
        10     7      0.07843      0.01587     0.50299    0.047653    0.07514    0.93085 
        11     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
        12     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
 
 
36 
 Estimated lymphedema probability by using 20.7% incidence of lymphedema           
 
                                                                       phat_      phat_ 
       Obs    ind    caseprobs    contprobs      phat     Var_phat     lower      upper 
 
         1     1      0.09804      0.25397     0.07327    0.001124    0.00756    0.13898 
         2     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         3     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         4     3       .           0.00794      .          .          0.00000     . 
         5     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         6     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         7     5      0.15686      0.41270     0.07223    0.000704    0.02023    0.12422 
         8     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
         9     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
        10     7      0.07843      0.01587     0.50299    0.047653    0.07514    0.93085 
        11     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
        12     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
 
 
 
 
Estimated lymphedema probability by using 25.5% incidence of lymphedema           
 
                                                                       phat_      phat_ 
       Obs    ind    caseprobs    contprobs      phat     Var_phat     lower      upper 
 
         1     1      0.09804      0.25397     0.07327    0.001124    0.00756    0.13898 
         2     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         3     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         4     3       .           0.00794      .          .          0.00000     . 
         5     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         6     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         7     5      0.15686      0.41270     0.07223    0.000704    0.02023    0.12422 
         8     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
         9     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
        10     7      0.07843      0.01587     0.50299    0.047653    0.07514    0.93085 
        11     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
        12     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
37 
  
            Estimated lymphedema probability by using 46.3% incidence of lymphedema           
 
                                                                       phat_      phat_ 
       Obs    ind    caseprobs    contprobs      phat     Var_phat     lower      upper 
 
         1     1      0.09804      0.25397     0.07327    0.001124    0.00756    0.13898 
         2     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         3     2      0.19608      0.14286     0.21944    0.004930    0.08181    0.35706 
         4     3       .           0.00794      .          .          0.00000     . 
         5     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         6     4      0.05882      0.00794     0.60287    0.077144    0.05848    1.00000 
         7     5      0.15686      0.41270     0.07223    0.000704    0.02023    0.12422 
         8     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
         9     6      0.27451      0.15079     0.27159    0.005344    0.12831    0.41488 
        10     7      0.07843      0.01587     0.50299    0.047653    0.07514    0.93085 
        11     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
        12     8      0.13725      0.00794     0.77984    0.034057    0.41813    1.00000 
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